IMVT-1402

· Immunovant Sciences GmbH

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for IMVT-1402, covering 2026-03-30 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD) [Phase 2]